Panacea Biotec awarded the manufacturing license to produce Sputnik V
Panacea Biotec awarded the manufacturing license to produce Sputnik V: Pharmaceutical firm Panacea Biotec said that it has received manufacturing license from Drugs Controller General of India (DCGI) for Sputnik V vaccine against Covid-19 pursuant to its collaboration with Russian Direct Investment Fund (Russia’s sovereign wealth fund).

Comments
Post a Comment